scholarly journals Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study

2019 ◽  
Vol Volume 11 ◽  
pp. 8539-8546 ◽  
Author(s):  
Yu-Hung Fang ◽  
Yao-Hsu Yang ◽  
Meng-Jer Hsieh ◽  
Ming-Szu Hung ◽  
Yu-Ching Lin
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Population Based ◽  
Population Based Study ◽  
Lung Cancer Patients ◽  
Risk Of Death ◽  
Increase Risk ◽  
Gefitinib Treatment

Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: A population-based study

Lung Cancer ◽  
1998 ◽  
Vol 21 (2) ◽  
pp. 105-113 ◽  
Author(s):  
Maryska L.G Janssen-Heijnen ◽  
Rob M Schipper ◽  
Peter P.A Razenberg ◽  
Mariad A Crommelin ◽  
Jan-Willem W Coebergh
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Population Based ◽  
Population Based Study ◽  
Lung Cancer Patients ◽  
Co Morbidity

scholarly journals Change in treatment modality and trends in survival among stage I non-small cell lung cancer patients: a population-based study

2020 ◽  
Vol 12 (9) ◽  
pp. 4670-4679
Author(s):  
Gileh-Gol Akhtar-Danesh ◽  
Christian Finley ◽  
Hsien Yeang Seow ◽  
Saad Shakeel ◽  
Noori Akhtar-Danesh
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Treatment Modality ◽  
Population Based ◽  
Small Cell ◽  
Small Cell Lung ◽  
Population Based Study ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document